Plain-English translation of NCT06568081 on ClinicalTrials.gov ↗ ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a digital therapy program called SloMoR2 that helps people experiencing psychosis—particularly paranoia—by delivering therapy through an app or digital platform. The study will see whether SloMoR2 works well when used in regular NHS mental health clinics by different types of therapists, and whether it's worth the investment. Researchers will track how people feel before and after using the treatment, and check in with them a year later.
Psychosis can be isolating and frightening, and many people don't have easy access to specialized therapy. This study exists to find out whether delivering therapy through a digital tool could make treatment more accessible and whether it actually helps people get better.
You likely qualify if…
You likely don't qualify if…
You would use the digital therapy program (SloMoR2) with support from a therapist at your NHS mental health service over several weeks or months. Before you start, during treatment, and 12 months later, you'll complete questionnaires about how you're feeling. The research team will also look at how the app is working, whether it's easy to use, and whether you're finding it helpful—partly through your own feedback and partly through data collected by the app itself.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
United Kingdom